Quarterly Result14 May 2026, 11:11 pm
Sai Life Sciences: FY26 Revenue ₹21,532.26 Mn
AI Summary
Sai Life Sciences Ltd's audited financial results for the year ended March 31, 2026, reveal a revenue from operations of ₹21,532.26 million, compared to ₹16,420.48 million in the previous year. The company's net profit for the year stood at ₹3,414.81 million, up from ₹1,734.62 million in FY25. The Board of Directors approved these results at a meeting held on May 14, 2026. Total assets increased from ₹31,366.63 million in FY25 to ₹36,028.16 million in FY26.
Key Highlights
- FY26 revenue from operations reached ₹21,532.26 million, a significant increase from ₹16,420.48 million in FY25.
- Net profit for FY26 was ₹3,414.81 million, substantially higher than the ₹1,734.62 million reported in FY25.
- Total expenses for FY26 amounted to ₹17,381.83 million, compared to ₹14,476.67 million in the previous year.
- Basic earnings per share increased to ₹16.27 in FY26 from ₹9.00 in FY25.
- The Board of Directors approved the audited financial results on May 14, 2026.
Price Impact
More from SAILIFE